Logo KMS TEAM
Precise execution

MC Services is...

Client News

 

 

… an international Corporate Communications and Investor Relations firm providing high-level consultancy with targeted services and support for transaction-oriented assignments throughout Europe and the United States.

 

read more

 

MC Services AG is looking forward to BIO-Europe 2016 in Cologne

 

Organized by the EBD Group, the 22nd BIO-Europe, the international partnering conference, this year will take place in Cologne, Germany from November 7 to 9, 2016. Serving the global life science industry, BIO-Europe offers various opportunities for high quality networking by attracting a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts. As media partner, MC Services invites local and international journalist to the event and keeps them informed on the presenting company executives and attending investors. Additional Information on MC Services’ engagement and activities during the conference will be announced soon.

 

Please follow us on Twitter (@MCServicesAG)
 

Congressman Donald M. Payne, Jr. Introduces Bipartisan 2016 Colorectal Cancer Detection Act

www.epigenomics.com

MorphoSys and Galapagos Start First-In-Patient Dosing of IL-17C Antibody MOR106 in Atopic Dermatitis

www.morphosys.de

Medigene AG: bluebird bio and Medigene establish strategic T cell receptor (TCR) alliance in cancer immunotherapy 

www.medigene.de

Boehringer Ingelheim boosts immune-oncology pipeline through collaboration with ViraTherapeutics

www.viratherapeutics.com

Edison publishes SYGNIS research update and sees Expedeon acquisition as solid basis for future growth

www.sygnis.com

4SC sells immunology portfolio to Immunic

www.4sc.com

WILEX AG: Subsidiary Heidelberg Pharma contracts Suisse CDMO Celonic for antibody cell line development and antibody production

www.wilex.de

ERYTECH Completes Patient Enrollment in Phase 2 Trial of eryaspase (GRASPA) for Pancreatic Cancer

www.erytech.com

Appointment of CFO

www.veronapharma.com

Cinfa Biotech starts second clinical study of pegfilgrastim biosimilar candidate B12019 

www.cinfabiotech.com

RedHill Biopharma and IntelGenx Announce RIZAPORT(R) Commercialization Term Sheet with Pharmatronic Co. for Korea

www.redhillbio.com

Unaudited Interim results for the six months ended 30 June 2016

www.ergomedplc.com

Medigene participates at five national and international conferences 

www.medigene.de

Adocia received the EY Global Company Award for the Auvergne Rhône-Alpes region

www.adocia.fr